North Carolina 2021-2022 Session Status: In Committee 1 D cosponsors

HB 862 — Improve Access to Patient Care.

Last action — Passed 1st Reading

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 2021-2022 Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Bill Text

What changed in the latest version

19 added · 18 removed

Plain-language change summary

The amendment to House Bill 862 adds a provision allowing physicians to include advanced practice providers in collaborative practice agreements. This change is important because it expands the scope of healthcare collaboration, enabling more efficient care management and better patient access to services. Additionally, it ensures that any rules developed by the Medical Board and the Board of Pharmacy will only take effect after being approved by both boards.

→
Previous
Latest
GENERAL ASSEMBLY OF NORTH CAROLINA H.B.
GENERAL ASSEMBLY OF NORTH CAROLINA SESSION 2021 H 1 HOUSE BILL 862 Short Title:
862 May 4, 2021 SESSION 2021 HOUSE PRINCIPAL CLERK H D HOUSE BILL DRH40540-NB-137 Short Title:
For a complete list of sponsors, refer to the North Carolina General Assembly web site.
A BILL TO BE ENTITLED AN ACT TO IMPROVE ACCESS TO PATIENT CARE SERVICES VIA COLLABORATION BETWEEN PHYSICIANS AND PHARMACISTS.
Health, if favorable, Rules, Calendar, and Operations of the House May 5, 2021 A BILL TO BE ENTITLED AN ACT TO IMPROVE ACCESS TO PATIENT CARE SERVICES VIA COLLABORATION BETWEEN PHYSICIANS AND PHARMACISTS.
(i) the implementation of predetermined drug therapy which includes diagnosis and product selection bythepatient'sphysician;(ii)modificationofprescribeddrugdosages,dosage forms, and dosage schedules;
(i) the implementation of predetermined drug therapy which includes diagnosis and product selection bythepatient'sphysician;
(ii)modificationofprescribeddrugdosages,dosage forms, and dosage schedules;
*DRH40540-NB-137* General Assembly Of North Carolina Session 2021 (1) TheNorth CarolinaMedicalBoardandtheNorthCarolinaBoardofPharmacy have adopted rules developed by a joint subcommittee governing the approval of individual clinical pharmacist practitioners to practice drug therapy management with such limitations use and oversight of collaborative practice in patient care settings and that the Boards shall determine to be in the best interest of patient health and safety.
*H862-v-1* General Assembly Of North Carolina Session 2021 (1) TheNorth CarolinaMedical BoardandtheNorthCarolinaBoardofPharmacy have adopted rules developed bya joint subcommittee governingthe approval of individual clinical pharmacist practitioners to practice drug therapy management with such limitations use and oversight of collaborative practice in patient care settings and that the Boards shall determine to be in the best interest of patient health and safety.
The physician shall conduct periodic review and evaluation of the clinical pharmacist practitioner as stated in the agreement between thephysician and clinical pharmacist practitioner.Aphysicianmay collaborate with and supervise as many clinical pharmacist practitioners as the physician deems can be safely and effectively supervised." SECTION 1.(d) G.S.
The physician shall conduct periodic review and evaluation of the clinical pharmacist practitioner as stated in the agreement between thephysician and clinical pharmacist practitioner.
Aphysicianmaycollaborate with and supervise as many clinical pharmacist practitioners as the physician deems can be safely and effectively supervised." SECTION 1.(d) G.S.
The North Carolina Board of Pharmacy has the authority to determine reasonable fees to accompany an the registry application for approval not to exceed one hundred dollars ($100.00) fifty dollars Page 2 DRH40540-NB-137 General Assembly Of North Carolina Session 2021 ($50.00) and for annual renewal of approval registration not to exceed fifty dollars ($50.00).
The North Carolina Board of Pharmacy has the authority to determine reasonable fees to accompany an the registry application for approval not to exceed one hundred dollars ($100.00) fifty dollars Page 2 House Bill 862-First Edition General Assembly Of North Carolina Session 2021 ($50.00) and for annual renewal of approval registration not to exceed fifty dollars ($50.00).
Rules recommended by the joint subcommittee shall be made and adopted in accordance with Chapter 150B of the General Statutes by both the North Carolina Medical Board and the North Carolina Board of Pharmacy and shall not become effective until adopted by both Boards.
Rules recommended by the joint subcommittee shall be made and adopted in accordance with Chapter 150B of the General Statutes by both the North Carolina Medical Board and the North Carolina Board of Pharmacyand shall not become effective until adopted by both Boards.
(b) Physiciansmayadd advancedpracticeprovidersto acollaborativepracticeagreement if the physician supervises them in another manner separate from the collaborative practice agreement.
(b) Physicians mayadd advancedpracticeprovidersto acollaborativepracticeagreement if the physician supervises them in another manner separate from the collaborative practice agreement.
The evaluation and supervision of the clinical pharmacist practitioner shall remain with the supervising physician and not any other health care provider included in the agreement." SECTION 4.(a) G.S.
The evaluation and supervision of the clinical pharmacist practitioner shall remain with the supervising physician and not anyother health care provider included in the agreement." SECTION 4.(a) G.S.
"(b3) "Collaborative care services" means patient care services that are designated in a written agreement that is authorized by a physician and delegated to a pharmacist for the purpose of drug therapy and disease management.
"(b3) "Collaborative care services" means patient care services that are designated in a written agreement that is authorized bya physician and delegated to a pharmacist for the purpose of drug therapy and disease management.
Article 4A of Chapter 90 of the General Statutes is amended by adding a new section to read:
Article 4A of Chapter 90 of the General Statutes is amended byadding a new section to read:
DRH40540-NB-137 Page 3
House Bill 862-First Edition Page 3
⬇ Download PDF
View plain text versions (2)

Action History

  1. Passed 1st Reading

  2. Ref to the Com on Health, if favorable, Rules, Calendar, and Operations of the House

  3. Filed

Sponsors

  • Sasser · Cosponsor
  • Carter · Cosponsor
  • Garland E. Pierce · Cosponsor
  • Wray · Cosponsor

Sponsorship breakdown

Export CSV (upgrade) →

0 sponsors · 4 co-sponsors · 175 not signed on

Sponsors (0)

None.

Co-sponsors (4)

Not signed on (175)

175 members have not signed on to this bill.

Show all 175 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors HB 862?
HB 862 is sponsored by Sasser, Carter, Garland E. Pierce (Democratic), and Wray.
What is the current status of HB 862?
This bill died with 2021-2022 Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track HB 862?
Track HB 862 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 862

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB 862

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →